Study to evaluate the efficacy of Systane Balance in reducing Symptoms and Inflammatory Biomarker expression of HLA-DR and Tear Film Cytokines in Dry Eye subjects with Lipid Deficiency
ID Number 13-0146Principal Investigator(s)
Penny A. Asbell
Department(s) or Division(s)
The primary objective of this study is to evaluate the ability of Systane Balance and Systane Gel to improve comfort over baseline after 30 days.
Recruiting Patients: No